At the beginning of 2012, the Italian Competition Authority adopted an infringement decision against Pfizer Italia s.r.l., Pfizer Health AB, and Pfizer Inc. ("Pfizer") and imposed a fine of EUR 10.6 million for an abuse of dominant position.
In a decision issued on 8 August 2011, the Italian authority had also rejected commitments suggested by Pfizer.
On 3 September 2012, the Italian Administrative Tribunal ("Tribunale Amministrativo di Lazio"—TAR Lazio) quashed the decision of the Italian authority, holding that Pfizer's conduct was legitimate.
Click here to download PDF.
This publication is provided for your convenience and does not constitute legal advice. This publication is protected by copyright.
© 2012 White & Case LLP